Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial Therapy
- 1 May 2017
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 15 (5) , 746-755.e4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative StudyAnnals of Surgical Oncology, 2010
- Assessing the Performance of Prediction ModelsEpidemiology, 2010
- The Staging of Cancer: A Retrospective and Prospective AppraisalCA: A Cancer Journal for Clinicians, 2008
- Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolizationCancer, 2007
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Staging systems for hepatocellular carcinoma: Should we all use the BCLC system?Journal of Hepatology, 2006
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958